Andrew L. Ross's most recent trade in iSpecimen Inc was a trade of 10,000 Option done . Disclosure was reported to the exchange on Jan. 2, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| iSpecimen Inc | Andrew L. Ross | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 10,000 | 33,525 | - | - | Option | |
| iSpecimen Inc | Andrew L. Ross | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 10,000 | 23,525 | - | - | Option | |
| iSpecimen Inc | Andrew L. Ross | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 125 | 1,326,340 | - | - | Common Stock | |
| iSpecimen Inc | Andrew L. Ross | Director | 31 Dec 2022 | 625 | 1,326,215 | - | - | Common Stock |